Literature DB >> 15025793

Ovarian neoplasms in patients with colorectal cancer: understanding the role of prophylactic oophorectomy.

Nader N Hanna1, Alfred M Cohen.   

Abstract

Although the role of prophylactic oophorectomy is currently under debate and not well defined, it is of increasing and considerable relevance, especially in premenopausal women, particularly those with identifiable hereditary cancer syndromes. Patients with colorectal cancer with ovarian metastases are often symptomatic, require surgery, and have poor survival. Prophylactic oophorectomy abolishes the increased risk of primary ovarian cancer in these patients, resects synchronous metastases, and prevents development of metachronous ovarian metastases. Prophylactic oophorectomy trials, mostly conducted in postmenopausal women, have not shown survival advantage. In patients with ovarian metastases of colorectal cancer, maximal cytoreductive surgery followed by adjuvant therapy employing newer chemotherapeutic agents, whole abdominal irradiation with chemosensitization, or hyperthermic intraperitoneal chemotherapy may improve outcomes in selected patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025793     DOI: 10.3816/CCC.2004.n.002

Source DB:  PubMed          Journal:  Clin Colorectal Cancer        ISSN: 1533-0028            Impact factor:   4.481


  17 in total

1.  Clinical and genetic determinants of ovarian metastases from colorectal cancer.

Authors:  Karuna Ganesh; Ronak H Shah; Efsevia Vakiani; Garrett M Nash; Hugh P Skottowe; Rona Yaeger; Andrea Cercek; Anne Lincoln; Christina Tran; Neil H Segal; Diane L Reidy; Anna Varghese; Andrew S Epstein; Yukio Sonoda; Dennis Chi; Jose Guillem; Larissa Temple; Philip Paty; Jaclyn Hechtman; Jinru Shia; Martin Weiser; Julio Garcia Aguilar; Nancy Kemeny; Michael F Berger; Leonard Saltz; Zsofia K Stadler
Journal:  Cancer       Date:  2016-11-22       Impact factor: 6.860

Review 2.  Prognosis and factors affecting colorectal cancer with ovarian metastasis.

Authors:  Fangyue Zhou; Jingxin Ding
Journal:  Updates Surg       Date:  2021-02-01

3.  Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer.

Authors:  Carling Ursem; Margaret Zhou; Alan Paciorek; Chloe E Atreya; Andrew H Ko; Alan Venook; Li Zhang; Katherine Van Loon
Journal:  Oncologist       Date:  2020-02-07

4.  Clinicopathologic and immunohistochemical profile of ovarian metastases from colorectal carcinoma.

Authors:  Gozde Kir; Ayse Gurbuz; Ates Karateke; Mustafa Kir
Journal:  World J Gastrointest Surg       Date:  2010-04-27

5.  Diagnosis of primary versus metastatic ovarian adenocarcinoma using p53 gene mutation analysis.

Authors:  Tomoki Yamano; Eiichi Morii; Isao Arai; Toshiaki Takada; Ken Kubota; Masahiko Sato; Takaaki Inoue; Yoshihiro Okada; Takahiko Hara; Katsuyuki Aozasa
Journal:  Int J Clin Oncol       Date:  2010-06-01       Impact factor: 3.402

6.  Ovarian transposition and metachronous ovarian metastasis in a premenopausal colorectal carcinoma patient: a case report.

Authors:  Shari Bodofsky; Sean Hong; George N Botros; Evita Sadimin; Patrick M Boland; Matthew P Deek
Journal:  J Gastrointest Oncol       Date:  2021-12

7.  Ovarian metastases in young women with colorectal cancer: a retrospective multicenter cohort study.

Authors:  R van der Meer; C Bakkers; J A Wegdam; T Lettinga; E G Boerma; F Aarts; I H J T de Hingh; R M H Roumen
Journal:  Int J Colorectal Dis       Date:  2022-07-20       Impact factor: 2.796

8.  Ovarian metastases of colorectal and duodenal cancer in familial adenomatous polyposis.

Authors:  Stijn Crobach; Tom van Wezel; Hans F Vasen; Hans Morreau
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

9.  Robotic surgery for rectosigmoid junction tumor with ovarian metastases.

Authors:  Abdulkadir Bedirli; Bulent Salman
Journal:  J Minim Access Surg       Date:  2015 Jan-Mar       Impact factor: 1.407

10.  Clinical outcomes of women with ovarian metastases of colorectal cancer treated with oophorectomy with respect to their somatic mutation profiles.

Authors:  Yoshiko Mori; Akihiro Nyuya; Kazuya Yasui; Toshiaki Toshima; Takashi Kawai; Fumitaka Taniguchi; Keisuke Kimura; Ryo Inada; Masahiko Nishizaki; Junko Haraga; Keiichiro Nakamura; Yuzo Umeda; Hiroyuki Kishimoto; Toshiyoshi Fujiwara; Yosuke Katata; Yoshiyuki Yamaguchi; Takeshi Nagasaka
Journal:  Oncotarget       Date:  2018-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.